Financhill
Back

Gritstone Bio 10K Form

Sell
11

GRTS
Gritstone Bio

Last Price:
0.82
Seasonality Move:
-25.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GRTS News And Ratings

See the #1 stock for the next 7 days that we like better than GRTS

GRTS Financial Statistics

Sales & Book Value

Annual Sales: $1.33M
Cash Flow: $-19.7M
Price / Cash Flow: 0
Annual Sales: $0.53
Price / Book: 1.4

Profitability

EPS (TTM): -1.20000
Net Income (TTM): $-138.49M
Gross Margin: --
Return on Equity: -126.58%
Return on Assets: -66.69%

Gritstone Bio Earnings Forecast

Key Gritstone Bio Financial Ratios

  • The Research & Development expenses have been 9,555.37% of Revenue.
  • The Interest Expense is -2.91% of Operating Income.
  • The Net Earning history of GRTS is -10,404.96% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Gritstone Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GRTS
CUSIP: 39868T
Website: gritstonebio.com

Debt

Debt-to-Equity Ratio: 0.77
Current Ratio: 3.2
Quick Ratio: 2.91

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GRTS Technical Analysis vs Fundamental Analysis

Sell
11
Gritstone Bio (GRTS) is a Sell

Is Gritstone Bio a Buy or a Sell?

  • Gritstone Bio stock is rated a Sell
    The current Gritstone Bio [GRTS] share price is $0.74. The Score for GRTS is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.